Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. It offers medical care and supplemental benefit plans to individuals. The company also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, it provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; and military services, such as TRICARE T2017 East Region contract. Further, the company engages in the operation of pharmacy benefit manager business; operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. It sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Medicare Maverick | Explore Humana's strategic positioning in the Medicare Advantage market, facing challenges with star ratings while pursuing ambitious growth targets |
Financial Fortitude | Delve into Humana's robust financial health, marked by strong profitability metrics and cash flow generation, despite ongoing industry pressures |
Growth Trajectory | Uncover Humana's plan to boost EPS to $37-$44 by 2028, driven by star rating improvements, cost reductions, and expansion of value-based care services |
Market Valuation | Analyst price targets range from $268 to $315, reflecting mixed opinions on Humana's near-term challenges balanced against long-term growth potential |
Metrics to compare | HUM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHUMPeersSector | |
---|---|---|---|---|
P/E Ratio | 20.0x | −32.0x | −0.7x | |
PEG Ratio | −3.04 | −1.00 | 0.00 | |
Price/Book | 1.7x | 3.9x | 2.6x | |
Price / LTM Sales | 0.3x | 1.0x | 3.4x | |
Upside (Analyst Target) | 7.0% | 13.5% | 37.8% | |
Fair Value Upside | Unlock | 4.2% | 5.5% | Unlock |